Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
07/2013
07/02/2013US8476450 Luminogenic and fluorogenic compounds and methods to detect molecules or conditions
07/02/2013US8476448 Solid form of 4-[[(6-chloropyridin-3-yl)methyl](2,2-difluoroethyl)amino]furan-2(5H)-one
07/02/2013US8476445 Process for production of piperidine derivatives
07/02/2013US8476442 Process for making modulators of cystic fibrosis transmembrane conductance regulator
07/02/2013US8476434 Protein kinase modulators and method of use
07/02/2013US8476430 Fused heterocyclic compounds useful as kinase modulators
07/02/2013US8476429 Tri-, tetra-substituted-3-aminopyrrolidine derivative
07/02/2013US8476416 comprises a dinucleotide analog that includes a non-naturally occurring pyrimidine base; for treating autoimmune disorders, such as autoimmune asthma; allergies
07/02/2013US8476320 Formulations for parenteral administration of amino-substituted (E)-2, 6-dialkoxystyryl 4-substituted benzylsulfones
07/02/2013US8476319 Methods of treating ear infections
07/02/2013US8476318 Polyethylene glycol esters and cosmetic and/or dermatological preparations
07/02/2013US8476317 N-alkylcarbonyl-amino acid ester compounds and their use for cough and pharyngitis
07/02/2013US8476316 3-methanesulfonylpropionitrile for treating inflammation and pain
07/02/2013US8476315 N-hydroxy C29-amide derivatives of oleandrane
07/02/2013US8476314 Substance with sedative effect
07/02/2013US8476313 Heteroaryl-containing isoflavones as aromatase inhibitors
07/02/2013US8476312 Composition comprising (−)-Δ9-trans-tetrahydrocannabinol
07/02/2013US8476311 Composition for treating influenza A (H1N1) virus and a preparation method therefor
07/02/2013US8476310 Docetaxel formulations with lipoic acid
07/02/2013US8476309 Benzofuran cannabinoid compounds and related methods of use
07/02/2013US8476308 GPR120 receptor agonists and uses thereof
07/02/2013US8476307 Pharmaceutical composition based on idazoxan, salts, hydrates or polymorphs thereof
07/02/2013US8476306 Urokinase inhibitors, production and use thereof
07/02/2013US8476305 Therapeutic agent or prophylactic agent for inflammatory bowel disease comprising amino alcohol derivative as active ingredient
07/02/2013US8476304 Method for decreasing symptoms of alcohol consumption
07/02/2013US8476303 N-aminopyrrolylmethyltetrahydropyridines as anti-cancer agents
07/02/2013US8476302 α-ketoamide derivatives useful endothelial lipase inhibitors
07/02/2013US8476301 Pyrrolidin-3-ylacetic acid derivative
07/02/2013US8476300 Selective estrogen receptor modulator for the treatment of osteoarthritis
07/02/2013US8476299 Crystalline form of a biphenyl compound
07/02/2013US8476298 c-Met modulators and method of use
07/02/2013US8476297 TRP-M8 receptor ligands and their use in treatments
07/02/2013US8476296 Preparation and therapeutic applications of (2S,3R)-N-2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]OCT-3-yl)-3,5-difluorobenzamide
07/02/2013US8476295 Bridged bicyclic RHO kinase inhibitor compounds, composition and use
07/02/2013US8476294 1H-imidazo[4,5-c]quinolinone derivatives
07/02/2013US8476293 Tricyclic compound and use thereof
07/02/2013US8476292 Amide and carbamate derivatives of N-{2-[4-amino-2-(ethoxymethyl)-1H-imidazo[4,5-c] quinolin-1-Yl]-1,1-dimethylethyl}methanesulfonamide and methods
07/02/2013US8476291 Opioid salts and formulations exhibiting anti-abuse and anti-dumping properties
07/02/2013US8476290 Compound having spiro-bonded cyclic group and use thereof
07/02/2013US8476289 Aza-bicyclohexyl substituted indolyl alkyl amino derivatives as novel inhibitors of histone deacetylace
07/02/2013US8476288 Salts 756
07/02/2013US8476287 3-hydroxy-5-arylisothiazole derivative
07/02/2013US8476286 Quinazoline derivatives which promote the release of parathyroid hormone
07/02/2013US8476285 Purine-core inhibitors of HSP90 and their use in treating cancer
07/02/2013US8476284 Inhibitors of Bruton's tyrosine kinase
07/02/2013US8476283 [6,5]—bicyclic GPR119 G protein-coupled receptor agonists
07/02/2013US8476282 Benzoxazole kinase inhibitors and methods of use
07/02/2013US8476280 Compositions and methods for combating lower urinary tract dysfunctions with delta opioid receptor agonists
07/02/2013US8476279 Phenyl-piperazine derivatives as serotonin reuptake inhibitors
07/02/2013US8476278 Thiazole Derivatives as protein kinase inhibitors
07/02/2013US8476277 TRPV1 antagonists including dihydroxy substituent and uses thereof
07/02/2013US8476276 Pharmaceutical compositions based on kinin B2 receptor antagonists and corticosteroids, and their use
07/02/2013US8476275 N-[piperazinyl hetaryl]arylsufonamide compounds with affinity for the dopamine D3 receptor
07/02/2013US8476274 Biaryl spiroaminooxazoline analogues as Alpha2C adrenergic receptor modulators
07/02/2013US8476273 Small molecule inhibitors of Lck SH2 domain binding
07/02/2013US8476272 Pharmaceutical composition for treatment of type 2 diabetes
07/02/2013US8476271 Substituted-quinoxaline-type bridged-piperidine compounds as ORL-1 modulators
07/02/2013US8476270 Dihydropyrido[4,3-b]pyrazine-3-ones as modulators of toll-like receptors
07/02/2013US8476269 Pyridine and pyrazine derivative for the treatment of CF
07/02/2013US8476268 Pyrrolidine-1,2-dicarboxamide derivatives
07/02/2013US8476267 Imidazo-, pyrazolopyrazines and imidazotriazines and their use
07/02/2013US8476266 Phenylacetic acid compound
07/02/2013US8476265 Compounds-801
07/02/2013US8476264 N-(3-(2-amino-6,6-difluoro-4,4A,5,6,7,7A-hexahydro-cyclopenta[E][1,3]oxazin-4-yl)-phenylamides as BACE1 inhibitors
07/02/2013US8476263 Prodrugs of 2,4-pyrimidinediamine compounds and their uses
07/02/2013US8476262 Cyanopyrroles
07/02/2013US8476261 Spirocyclic aminoquinolones as GSK-3 inhibitors
07/02/2013US8476260 Antitumor agent
07/02/2013US8476259 Fasudil in combination therapies for the treatment of pulmonary arterial hypertension
07/02/2013US8476258 Compound having activity of blocking NMDA receptor channel, and pharmaceutical agent using the same
07/02/2013US8476257 Viral polymerase inhibitors
07/02/2013US8476256 Diazonamide analogs
07/02/2013US8476255 Histone deacetylase inhibitors
07/02/2013US8476254 Methods for treating psychosis associated with interferson-α therapy
07/02/2013US8476253 Amide derivative
07/02/2013US8476252 Pharmaceutical emulsion compositions comprising progestogen
07/02/2013US8476250 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine
07/02/2013US8476249 Method of treating thrombocytopenia
07/02/2013US8476248 Process for the preparation of a water-soluble complex having resveratrol compounds; products comprising said complex; and uses thereof
07/02/2013US8476247 Method of reducing intraocular pressure in humans
07/02/2013US8476241 Effective treatment of esophogeal adenocarcinoma using triciribine and related compounds
07/02/2013US8476240 Histidine related compounds for identifying and blocking amyloid beta ion channels
07/02/2013US8476233 Methods for treatment for ulcerative colitis in mammals
07/02/2013US8476220 Biocompatible polymers, process for their preparation and compositions containing them
07/02/2013US8476208 Water-soluble metal-processing agent, coolant, method for preparation of the coolant, method for prevention of microbial deterioration of water-soluble metal-processing agent, and metal processing
07/02/2013US8476197 Aminopropenoates as fungicides
07/02/2013US8476192 Seed treatment pesticidal compositions
07/02/2013US8476040 Eukaryotic signal sequences for polypeptide expression and polypeptide display libraries
07/02/2013US8476010 Propofol formulations with non-reactive container closures
07/02/2013US8475850 Methods and compositions for heavy metal detoxification
07/02/2013US8475845 Method of particle formation
07/02/2013US8475842 Immediate release pharmaceutical formulation of 4-[3-(4-cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one
07/02/2013US8475841 Controlled release metformin formulations
07/02/2013US8475839 Solid dosage forms of valsartan, amlodipine and hydrochlorothiazide and method of making the same
07/02/2013US8475838 Rapidly-dissolving pharmaceutical composition for inhibiting ovulation
07/02/2013US8475837 Abuse potential reduction in abusable substance dosage form
07/02/2013US8475834 Method of improving absorption of vitamin E by a pet animal
07/02/2013US8475832 Sublingual and buccal film compositions
07/02/2013US8475828 Medical apparatus and method for producing same
07/02/2013US8475826 Titanium oxide-organic polymer conjunction suitable for artificial bone